Document is current

Any future updates will be listed below

A non‐randomized clinical trial to evaluate the effect of fingolimod on expanded disability status scale score and number of relapses in relapsing‐remitting multiple sclerosis patients

Crossref DOI link: https://doi.org/10.1186/s40169-019-0228-7

Published Online: 2019-04-08

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark